Title: The Diagnostic Value of MRI-PDFF in Hepatic Steatosis of Patients with metabolic
dysfunction-associated steatotic liver disease: A Systematic Review and Meta-Analysis
Version: 1 Date: 26 Mar 2025
Reviewer's report:
It's a good paper. I have 2 minor suggestions:
1) I recommend that you use the new nomenclature (i.e. MASLD) instead of NAFLD;
2) Please consider performing subgroup and meta-regression analyses to explore sources of
heterogeneity, including study and population characteristics.
Title: The Diagnostic Value of MRI-PDFF in Hepatic Steatosis of Patients with metabolic
dysfunction-associated steatotic liver disease: A Systematic Review and Meta-Analysis
Version: 1 Date: 26 Mar 2025
Reviewer's report:
It's a good paper. I have 2 minor suggestions:
1) I recommend that you use the new nomenclature (i.e. MASLD) instead of NAFLD;
2) Please consider performing subgroup and meta-regression analyses to explore sources of
heterogeneity, including study and population characteristics.
Please review this paper.
user
Title: The Diagnostic Value of MRI-PDFF in Hepatic Steatosis of Patients with metabolic
dysfunction-associated steatotic liver disease: A Systematic Review and Meta-Analysis
Version: 1 Date: 26 Mar 2025
Reviewer's report:
It's a good paper. I have 2 minor suggestions:
1) I recommend that you use the new nomenclature (i.e. MASLD) instead of NAFLD;
2) Please consider performing subgroup and meta-regression analyses to explore sources of
heterogeneity, including study and population characteristics.
assistant